December 2007 Briefing - Dermatology

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for December 2007. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Psychoeducation Does Not Improve Melanoma Outcome

MONDAY, Dec. 31 (HealthDay News) -- Psychoeducation has no impact on the recurrence-free interval or survival rates of patients with primary malignant melanoma, according to the results of a study published in the Dec. 20 issue of the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Dermatomyositis Diagnosis Varies By Medical Specialty

FRIDAY, Dec. 28 (HealthDay News) -- Dermatomyositis patients may receive different diagnoses depending on whether they're seen by a dermatologist or rheumatologist, and also according to the degree of their disease, researchers report in the December issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Alexandrite Laser Effective in Treating Facial Hirsutism

THURSDAY, Dec. 27 (HealthDay News) -- In women with polycystic ovary syndrome, the GentleLase alexandrite laser is more effective at reducing facial hirsutism than the Lumina IPL system, according to the results of a study published in the December issue of Lasers in Surgery and Medicine.

Abstract
Full Text (subscription or payment may be required)

OTC Wart-Freezing Products May Not Be Cold Enough

THURSDAY, Dec. 27 (HealthDay News) -- Patients should be cautioned against claims that over-the-counter (OTC) wart-freezing products are comparable to in-office cryotherapy, according to a report published in the December issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Roenigk Score for Liver Damage Reliable

MONDAY, Dec. 24 (HealthDay News) -- The Roenigk system to classify liver fibrosis is reliable with reasonable interobserver variability, according to a report in the December issue of Archives of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Researchers Rap Infantile Hemangiomas Web Sites

FRIDAY, Dec. 21 (HealthDay News) -- Among Internet sites that address infantile hemangiomas, most do not accurately depict the full disease spectrum from innocuous to severe, and many present a biased view of treatment options, researchers report in the December issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Higher Mortality Risk with Severe Psoriasis

FRIDAY, Dec. 21 (HealthDay News) -- Patients with severe psoriasis have a higher risk of mortality than those without the skin condition, researchers report in the December issue of the Archives of Dermatology.

Abstract
Full Text

Epidemiology of Herpes Zoster Reviewed

THURSDAY, Dec. 20 (HealthDay News) -- Herpes zoster occurs primarily in immunocompetent individuals aged 50 and older, according to a report published in the November issue of the Mayo Clinic Proceedings. The researchers also report that herpes zoster complications increase with age and affect one in four patients.

Abstract
Full Text (subscription or payment may be required)

Review Article Addresses Nevi, Melanoma During Pregnancy

THURSDAY, Dec. 20 (HealthDay News) -- Although confusion persists among practitioners about the impact of pregnancy and female hormones on melanocytic nevi and melanoma, recent studies offer guidance for effective management, according to a continuing medical education article published in the December issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Higher Rates of Lung Cancer in Lower UVB Light Areas

TUESDAY, Dec. 18 (HealthDay News) -- In a survey of 111 countries, places with lower levels of ultraviolet B (UVB) irradiance have higher incidence of lung cancer, according to research published in the January issue of the Journal of Epidemiology and Community Health.

Abstract
Full Text (subscription or payment may be required)

Many with Psoriasis Undertreated, Survey Finds

THURSDAY, Dec. 13 (HealthDay News) -- Contrary to major guidelines and consensus statements on recommended treatments for psoriasis, a sizable percentage of people with the condition report they're receiving no treatment, according to survey results published in the December issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Yeast Unrelated to Pustular Condition in Newborns

THURSDAY, Dec. 13 (HealthDay News) -- Colonization of newborns' skin with Malassezia yeast is common after the first week of life, and the yeast does not appear to be correlated with the development of neonatal cephalic pustulosis, according to research published in the December issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

First Partial Face Transplant Proves Successful

WEDNESDAY, Dec. 12 (HealthDay News) -- The surgeons who performed the first partial face transplantation on a woman with severe disfigurement from a dog bite report a positive functional and cosmetic result 18 months after the surgery, according to an article published in the Dec. 13 issue of the New England Journal of Medicine.

Abstract
Full Text

Patterns of Gene Expression Linked to Aging

THURSDAY, Dec. 6 (HealthDay News) -- Researchers have uncovered patterns in alterations of gene expression and major regulators related to aging with the transcription factor NF-κB most strongly associated with age-dependent changes, according to research released online Nov. 30 in Genes and Development.

Abstract
Full Text

Drug Shows Promise for Skin Cancer Prevention, Treatment

WEDNESDAY, Dec. 5 (HealthDay News) -- A drug that targets a mutant cancer protein can prevent and treat ultraviolet light-induced skin tumors in a non-immunodeficient mouse model and in human skin carcinoma cells, according to a study in the Dec. 3 issue of the Journal of Clinical Investigation.

Abstract
Full Text
Editorial

Related Stories

No stories found.
logo
www.healthday.com